Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
about
Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@en
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@nl
type
label
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@en
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@nl
prefLabel
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@en
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@nl
P2860
P1476
Teprotumumab: a new avenue for ...... nd active Graves' orbitopathy?
@en
P2093
E Piantanida
L Bartalena
P2860
P2888
P304
P356
10.1007/S40618-017-0717-8
P577
2017-06-20T00:00:00Z